Article Details

Morgan Stanley Initiates Coverage on CRISPR Therapeutics (NASDAQ:CRSP) - MarketBeat

Retrieved on: 2022-10-11 23:51:59

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Initiates Coverage on CRISPR Therapeutics (NASDAQ:CRSP) - MarketBeat. View article details on hiswai: https://www.marketbeat.com/instant-alerts/nasdaq-crsp-a-buy-or-sell-right-now-2022-10-2/

Excerpt

Morgan Stanley initiated coverage on CRISPR Therapeutics in a report on Tuesday. They set an "underweight" rating on the stock.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up